ProShare Advisors
ALIM

ProShare Advisors’s Alimera Sciences ALIM Stock Holding History

ProShare Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,451
Closed -$81K – 1727
2015
Q3 		$81K Sell
2,451
-170
-6% -$9.57K ﹤0.01% 1395
2015
Q2 		$181K Sell
2,621
-96
-4% -$6.62K ﹤0.01% 1534
2015
Q1 		$204K Buy
2,717
+386
+17% +$30.4K ﹤0.01% 1715
2014
Q4 		$194K Buy
2,331
+1,636
+235% +$133K ﹤0.01% 1745
2014
Q3 		$56K Sell
695
-157
-18% -$13.4K ﹤0.01% 2249
2014
Q2 		$76K Sell
852
-291
-25% -$25.8K ﹤0.01% 2409
2014
Q1 		$135K Buy
+1,143
New +$111K ﹤0.01% 2630
2013
Q4 		– Sell
-714
Closed -$40K – 1928
2013
Q3 		$40K Buy
+714
New +$44.8K ﹤0.01% 2514

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ProShare Advisors's ALIM Position: Q4 2015 in Review

ProShare Advisors sold out of Alimera Sciences (ALIM) in Q4 2015, closing a stake of 2,451 shares — an estimated $81K sold.

ProShare Advisors first reported a position in ALIM in Q3 2013 and held it in 8 quarters. The position peaked at $204K in Q1 2015. 66 funds tracked by Wall St. Rank hold ALIM as of Q4 2015.

  • ProShare Advisors reported no remaining Alimera Sciences position as of Q4 2015 after selling out during the quarter.
  • ProShare Advisors sold 2,451 Alimera Sciences shares in Q4 2015, an estimated $81K.
  • ProShare Advisors first reported a position in Alimera Sciences in Q3 2013 and held it in 8 quarters.
  • ProShare Advisors's Alimera Sciences position peaked at $204K in Q1 2015.
  • 66 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2015.

Based on ProShare Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.